Literature DB >> 8271295

Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent.

R K Tiwari1, L Guo, H L Bradlow, N T Telang, M P Osborne.   

Abstract

BACKGROUND: Indole-3-carbinol (I3C), a compound found in cabbage, broccoli, and brussels sprouts, inhibits the growth of mammary tumors when fed to certain strains of mice. The chemopreventive and antitumor effects of I3C depend on the species and tissue type. The mechanism of action and specific human cell types that respond to I3C are not known.
PURPOSE: Our purpose was to study the mechanism of action of I3C in estrogen-responsive (MCF-7) and estrogen-nonresponsive (MDA-MB-231) human breast cancer cell lines.
METHODS: Estrogen responsiveness was determined by the ability of estradiol to stimulate the growth of breast cancer cells deprived of estrogen. The effect of I3C was measured on cell growth, estradiol metabolism, and level of cytochrome P-4501A1. Growth was measured by cell counts and soft-agar assay, estrogen metabolism was examined by a radiometric assay, and the level of cytochrome P-4501A1 was measured by Western blots with a polyclonal antibody.
RESULTS: I3C inhibits the growth of estrogen-responsive cell line MCF-7 but has little effect on estrogen-nonresponsive cell line MDA-MB-231. Specific C-2 hydroxylation of estrogen and induction of cytochrome P-4501A1 was enhanced by I3C in the MCF-7 but not in the MDA-MB-231 cells.
CONCLUSION: I3C has specific antigrowth effects in human breast cancer cells. The inhibitory effects of I3C may involve selective induction of estradiol metabolism and the related cytochrome P-450 system that may be limited to estrogen-sensitive cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8271295     DOI: 10.1093/jnci/86.2.126

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  17 in total

1.  Antiestrogenic activity of anthropogenic and natural chemicals.

Authors:  J M Navas; H Segner
Journal:  Environ Sci Pollut Res Int       Date:  1998       Impact factor: 4.223

2.  Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.

Authors:  Shadan Ali; Sanjeev Banerjee; Jacqueline M Schaffert; Bassel F El-Rayes; Philip A Philip; Fazlul H Sarkar
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

Review 3.  Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

Authors:  Min Ji Bak; Soumyasri Das Gupta; Joseph Wahler; Nanjoo Suh
Journal:  Semin Cancer Biol       Date:  2016-03-22       Impact factor: 15.707

4.  3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study.

Authors:  Shilpi Rajoria; Robert Suriano; Perminder Singh Parmar; Yushan Lisa Wilson; Uchechukwu Megwalu; Augustine Moscatello; H Leon Bradlow; Daniel W Sepkovic; Jan Geliebter; Stimson P Schantz; Raj K Tiwari
Journal:  Thyroid       Date:  2011-01-22       Impact factor: 6.568

Review 5.  Mammary tumorigenesis and chemoprevention studies in carcinogen-treated rats.

Authors:  C Ip
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

6.  Results from a dose-response study using 3,3'-diindolylmethane in the K14-HPV16 transgenic mouse model: cervical histology.

Authors:  Daniel W Sepkovic; Johann Stein; Antoine D Carlisle; H Barbara Ksieski; Karen Auborn; Laura Raucci; Themba Nyirenda; H Leon Bradlow
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-07

Review 7.  Medical hypothesis: bifunctional genetic-hormonal pathways to breast cancer.

Authors:  D L Davis; N T Telang; M P Osborne; H L Bradlow
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

8.  Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer.

Authors:  Shadan Ali; Sanjeev Banerjee; Aamir Ahmad; Bassel F El-Rayes; Philip A Philip; Fazlul H Sarkar
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

9.  Metastatic phenotype is regulated by estrogen in thyroid cells.

Authors:  Shilpi Rajoria; Robert Suriano; Arulkumaran Shanmugam; Yushan Lisa Wilson; Stimson P Schantz; Jan Geliebter; Raj K Tiwari
Journal:  Thyroid       Date:  2010-01       Impact factor: 6.568

10.  Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.

Authors:  Shilpi Rajoria; Robert Suriano; Andrea George; Arulkumaran Shanmugam; Stimson P Schantz; Jan Geliebter; Raj K Tiwari
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.